The 5 analysts offering 1 year price forecasts for SANGAMO THERAPEUTICS INC COM USD0.01 have a max estimate of 10.000 and a min estimate of 2.0000.
Analyst rating
Based on 7 analysts giving stock ratings to SANGAMO THERAPEUTICS INC COM USD0.01 in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
4
Buy
1
Hold
2
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.75
−0.50
−0.25
0.00
0.25
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.66
−0.59
−0.34
−0.27
−0.18
0.04
−0.11
—
—
—
—
Estimate
−0.34
−0.32
−0.26
−0.21
−0.15
−0.02
−0.09
−0.09
0.03
−0.13
−0.08
Surprise
−96.21%
−85.03%
−32.64%
−26.32%
−22.68%
+362.30%
−20.55%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
13.00 M
26.00 M
39.00 M
52.00 M
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
6.83 M
9.40 M
2.04 M
481.00 K
356.00 K
49.40 M
7.55 M
—
—
—
—
Estimate
16.75 M
9.36 M
8.11 M
6.36 M
6.88 M
20.92 M
11.70 M
19.30 M
44.57 M
6.20 M
13.00 M
Surprise
−59.19%
+0.41%
−74.81%
−92.43%
−94.83%
+136.18%
−35.46%
—
—
—
—
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0R1D EPS for the last quarter is −0.11 USD despite the estimation of −0.09 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of SANGAMO THERAPEUTICS INC COM USD0.01 financials and stay on top of what is up with the company.
We've gathered opinions of 7 analysts rating 0R1D stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.